Breast cancer accounts for one out of every three cancer diagnoses in America, with over 200,000 new cases expected in the year 2004, and claiming more than 40,000 lives. Breast cancer incidence has remained fairly steady over the past decade, at about 111 cases per 100,000.
Research has been the key to dramatic improvements in prevention, early detection, treatment and survivorship. Clinical treatment advances in radiation and surgery, as well as chemotherapies such as Tamoxifen, Herceptin all have been assisted through research selected and funded by the American Cancer Society.
These research efforts can continue only with new and increased support.
Joining with the American Cancer Society, the world's largest and most experienced private funder of cancer research, The Pearl Endowment will help eliminate the threat of breast cancer for future generations.
Each year, income from the Pearl Endowment will be used to fund the highest priority breast cancer research, which will be selected by the American Cancer Society.